Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024

BACKGROUND: For lymphatic filariasis (LF) elimination, the World Health Organization recommends multiple rounds of mass drug administration (MDA) to interrupt transmission. While LF antigen (Ag) is routinely used to monitor progress, recent evidence suggests more time-sensitive indicators are needed during the immediate post-MDA period. In Samoa, triple-drug MDA was distributed in 2018 and 2023. This study aimed to evaluate the impact of Samoa's second round of triple-drug MDA on human and mosquito-based indicators of transmission. METHODOLOGY: Surveys were conducted in eight primary sampling units (PSUs) in 2019 (6-9 months after the 2018 MDA), 2023 (4.5 years after the 2018 MDA) and 2024 (10 months after the 2023 MDA). Participants aged ≥5 years from randomly selected households were tested for Ag and microfilariae (Mf). For molecular xenomonitoring (MX), mosquitoes were caught using BG-Sentinel traps at households, sorted into pools by species, and tested for presence of filarial DNA using quantitative polymerase chain reaction (qPCR). RESULTS AND KEY FINDINGS: In 2024, Ag prevalence was 10.3% (95% CI: 7.3-14.5) versus 9.9% (95% CI: 3.5-21.0) in 2023 and 9.8% (95% CI: 5.6-15.5) in 2019. Mf prevalence was 3.1% (95% CI: 1.8-5.5) in 2024 vs 5.1% (95% CI:1.3-12.4) in 2023 and 3.1% (95% CI:1.3-5.9) in 2019. Odds ratios (OR) of a positive test in 2024 vs 2023 showed no decrease for Ag (OR 1.0; 95% CI: 0.7-1.6), but a potential reduction in the proportion of Ag-positive participants who were Mf-positive (OR 0.6; 95% CI: 0.2-1.4) and a significant reduction in the prevalence of qPCR-positive mosquitoes (OR 0.4; 95% CrI: 0.2-0.7). From 2019-2024, there were reductions in prevalence of qPCR-positive Aedes spp. (OR 0.5; 95% CrI: 0.3-1.0) and Aedes polynesiensis (OR 0.4; 95% CrI: 0.2-0.8). CONCLUSIONS: In Samoa, LF transmission continues despite two rounds of triple-drug MDA five years apart. Mosquito indicators can provide a more sensitive measure of MDA impact in the immediate post-intervention period and complement human indicators for long-term surveillance.

Authors

Institutions

Publication Details

Journal
PLoS neglected tropical diseases
Published
2026-10-15
DOI
https://doi.org/10.1371/journal.pntd.0013895
Primary Topic
Parasitic Diseases Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024

Patricia M. Graves, Donna Mackenzie, Brady McPherson, Benn K. D. Sartorius et al.
PLoS neglected tropical diseases
Parasitic Diseases Research and Treatment
article

Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024

Patricia M. Graves, Donna Mackenzie, Brady McPherson, Benn K. D. Sartorius, Beatris Mário Martin, Selina Rachael Ward, Helen J. Mayfield, Satupaitea Viali, Lisa Rigby, Colleen L. Lau, Angus McLure, Robert E. Thomsen, Joanne R. Kizu, Elina Panahi, Shannon M. Hedtke, Rhys Izuagbe, Asrhyella Seeler, Richard Bradbury
article en

Abstract

BACKGROUND: For lymphatic filariasis (LF) elimination, the World Health Organization recommends multiple rounds of mass drug administration (MDA) to interrupt transmission. While LF antigen (Ag) is routinely used to monitor progress, recent evidence suggests more time-sensitive indicators are needed during the immediate post-MDA period. In Samoa, triple-drug MDA was distributed in 2018 and 2023. This study aimed to evaluate the impact of Samoa's second round of triple-drug MDA on human and mosquito-based indicators of transmission. METHODOLOGY: Surveys were conducted in eight primary sampling units (PSUs) in 2019 (6-9 months after the 2018 MDA), 2023 (4.5 years after the 2018 MDA) and 2024 (10 months after the 2023 MDA). Participants aged ≥5 years from randomly selected households were tested for Ag and microfilariae (Mf). For molecular xenomonitoring (MX), mosquitoes were caught using BG-Sentinel traps at households, sorted into pools by species, and tested for presence of filarial DNA using quantitative polymerase chain reaction (qPCR). RESULTS AND KEY FINDINGS: In 2024, Ag prevalence was 10.3% (95% CI: 7.3-14.5) versus 9.9% (95% CI: 3.5-21.0) in 2023 and 9.8% (95% CI: 5.6-15.5) in 2019. Mf prevalence was 3.1% (95% CI: 1.8-5.5) in 2024 vs 5.1% (95% CI:1.3-12.4) in 2023 and 3.1% (95% CI:1.3-5.9) in 2019. Odds ratios (OR) of a positive test in 2024 vs 2023 showed no decrease for Ag (OR 1.0; 95% CI: 0.7-1.6), but a potential reduction in the proportion of Ag-positive participants who were Mf-positive (OR 0.6; 95% CI: 0.2-1.4) and a significant reduction in the prevalence of qPCR-positive mosquitoes (OR 0.4; 95% CrI: 0.2-0.7). From 2019-2024, there were reductions in prevalence of qPCR-positive Aedes spp. (OR 0.5; 95% CrI: 0.3-1.0) and Aedes polynesiensis (OR 0.4; 95% CrI: 0.2-0.8). CONCLUSIONS: In Samoa, LF transmission continues despite two rounds of triple-drug MDA five years apart. Mosquito indicators can provide a more sensitive measure of MDA impact in the immediate post-intervention period and complement human indicators for long-term surveillance.

PLoS neglected tropical diseasesVol. 20(10)
Australian National University (AU), Federation University (AU), The University of Queensland (AU), La Trobe University (AU), QIMR Berghofer Medical Research Institute (AU), Australian Defence Force Malaria and Infectious Disease Institute (AU), Oceania University of Medicine (WS), James Cook University (AU)
United States Agency for International Development, Bill and Melinda Gates Foundation, University of Queensland, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 12%
Parasitic Diseases Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.